 |
 |
 |
About this Podcast:
In this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCG’s President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted.
Explore Accurate Symptom Reporting for your study
Complete the form to request a schedule a consultation. We’ll assess your needs, review our training service and demonstrate how WCG can transform symptom reporting for your study.